MUSK and myasthenia gravis: In particular, patients with refractory MuSK-MG that exhibited long-term remission upon RTX initiation displayed undetectable or low levels of MuSK IgG4 antibody titers, whereas total IgG and IgG4 levels transiently decreased at 2–7 months after RTX.